Loading company…
Regenex develops reproductive health, chronic disease, and topical medicines.
Regenex develops and sells medicines for reproductive health, chronic disease, and topical use. Founded in 2003, the company is based in Guangzhou, China, and established an R&D center in 2011. Its products span male, female, and LGBT health, and its technology includes drug synthesis and controlled-release platforms. In June 2023, it raised over CNY 100 million in Series C funding from Chuangyu Capital, Fortune Capital, GF Xinde Investment, and Guangzhou Kechuang Guofa Industry Fund Management.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in